"AHEAD focuses on the development and application of AI-enabled diagnostic and disease assessment tools to blood cancer treatment.
AHEAD-flow platform is a blood cancer triage platform.
It fully automates clinical flow cytometry data analysis in 7 seconds.
It is designed to help physicians detecting abnormal specimens faster, hence, reduce the clinical decision delay and allowing timely
treatment for patients."
- Headquarter Regions
- San Francisco Bay Area, West Coast, Western US
- Founded Year
- Funding Status
- CES 2020